Viewbix: Quantum X Labs Announces Breakthrough in the Development of a Quantum Gyroscope Chip Technology GlobeNewswire January 06, 2026 The global quantum compass navigation is expected to experience robust growth in the upcoming years Tel Aviv, Israel, Jan. 06, 2026 (GLOBE NEWSWIRE) — Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the “Company”), an advanced technologies company, […]

NASHVILLE, Tenn., Jan. 06, 2026 (GLOBE NEWSWIRE) — TransCore today announced that the Delaware Department of Transportation (DelDOT) has successfully gone live with the latest generation of TransCore's Integrity(R) Back Office System, an upgrade that strengthens the reliability, accuracy, and scalability of Delaware's statewide tolling and E-ZPass operations, while delivering new customer service enhancements that

(NASDAQ:COEP), WEXFORD, Pa., Jan. 06, 2026 (GLOBE NEWSWIRE) — Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen technology and biopharmaceutical company, , announced today that its registration statement on Form S-4 (File No. 333-288329) (as amended, the “Registration Statement”), relating to the previously announced merger transaction (the “Transaction”) with Z Squared

Delaware Department of Transportation and TransCore Launch New Tolling Back Office System to Enhance Statewide Operations Next-generation Integrity(R) Back Office platform modernizes toll processing and E-ZPass(R) account management across Delaware GlobeNewswire January 06, 2026 NASHVILLE, Tenn., Jan. 06, 2026 (GLOBE NEWSWIRE) — TransCore today announced that the Delaware Department of Transportation (DelDOT) has successfully gone

Coeptis Therapeutics S-4 Declared Effective by SEC, Proxy Mailing Begins in Anticipation of the Merger Transaction with Z Squared ~ Annual/Special Meeting of Shareholders to be Held on January 30, 2026 ~ GlobeNewswire January 06, 2026 WEXFORD, Pa., Jan. 06, 2026 (GLOBE NEWSWIRE) — Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a

Washington, D.C., Jan. 06, 2026 (GLOBE NEWSWIRE) — Education company EAB announced today that it has acquired Hybrid, a UK-based leader in digital marketing for higher education, from private equity investor LDC. The combination of Hybrid's success growing global enrollments through integrated marketing and EAB's comprehensive enrollment solutions and expertise serving U.S. schools will enable

(NASDAQ:NUWE), MINNEAPOLIS, Jan. 06, 2026 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company advancing precision fluid management technologies across the cardio-renal continuum today announced that the United States Patent and Trademark Office recently issued a new U.S. patent covering advanced safety mechanisms for blood return line clamps used in extracorporeal blood filtration

(NASDAQ:ERNA), Regulatory alignment supports rapid progress, tech transfer already underway to accelerate clinical readiness Company on track to initiate first-in-human (FIH) trial for the treatment of ovarian cancer in the second half of 2026 CAMBRIDGE, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) — Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the

EAB Acquires Hybrid to Expand Global Reach and Enhance Digital Innovation Hybrid's AI-powered digital and creative capabilities will strengthen how colleges connect with learners worldwide GlobeNewswire January 06, 2026 Washington, D.C., Jan. 06, 2026 (GLOBE NEWSWIRE) — Education company EAB announced today that it has acquired Hybrid, a UK-based leader in digital marketing for higher

Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy Patent issuance strengthens pediatric intellectual property portfolio and advances system-level safety design GlobeNewswire January 06, 2026 MINNEAPOLIS, Jan. 06, 2026 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company advancing precision fluid management technologies across the cardio-renal continuum